Help with FT decision -- Choosing between banks

Hi guys, 

I need help with FT recruiting decision and deciding whether it is worth to switch. I am currently interning at a HC boutique doing Healthcare Services/HCIT M&A (Ziegler/Edgemont/Tripletree/Provident) but have an opportunity to switch to Mizuho, Oppenheimer, and WF HC teams. My end goal is go into PE and wondering is it worth to switch to these platforms which has historically been more cap raising heavy and not a lot M&A but has a better brand name. 

Also it is WF NYC office so concerned life sciences will not be as good for exits as HC Services/HCIT. Thanks and would love to learn your thoughts 

4 Comments
 

When deciding between staying at your current HC boutique or switching to Mizuho, Oppenheimer, or Wells Fargo (WF) HC teams, here are some key considerations based on the most helpful WSO content:

  1. End Goal Alignment (PE Focus):

    • If your goal is to break into PE, M&A experience is typically more valuable than capital-raising experience. PE firms often prioritize candidates with strong deal experience, particularly in M&A, as it aligns more closely with the skillset required in private equity.
    • Your current boutique, focused on Healthcare Services/HCIT M&A, might provide more relevant experience for PE recruiting compared to platforms that are more capital-raising heavy.
  2. Brand Name vs. Deal Experience:

    • While brand name matters, especially for networking and resume screening, it should not come at the expense of deal experience. If the platforms you're considering (Mizuho, Oppenheimer, WF) are more focused on capital markets and less on M&A, this could hinder your PE recruiting prospects.
    • WF's NYC office might offer better brand recognition, but if the life sciences focus doesn't align with your desired PE path (HC Services/HCIT), it may not be the best fit.
  3. Networking and Exit Opportunities:

    • Networking is critical for PE recruiting. If the new platforms provide better access to alumni or professionals in PE, this could be a factor in their favor.
    • However, if your current boutique has strong relationships with PE firms in the HC Services/HCIT space, this could be a significant advantage.
  4. Long-Term Perspective:

    • Consider the type of deals and exposure you’ll get at each platform. If your current boutique offers hands-on experience with smaller teams and more responsibility, this could be more valuable for skill-building and storytelling during PE interviews.

Recommendation:

If your current boutique is providing solid M&A experience in HC Services/HCIT and has a track record of placing analysts into PE, it might be better to stay. However, if the platforms you're considering (especially WF NYC) offer a clear path to better networking opportunities and PE exits, it could be worth the switch. Ultimately, prioritize deal experience and alignment with your long-term goals over brand name alone.

Sources: Offer Decision Help Needed, HF to PE post-MBA - my story and seeking advice (long-time poster)!, How to Navigate FT Recruiting: Learn from My Successes/Failures, Long Term HF recruiting, Rising Junior Losing Hope and In Need of Advice

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

About to start at wells ft for context.

I’d be hesitant about the wells hc offer. Historically the group has been very weak - heard a story about an analyst who went a full year without seeing a deal close - just tons of pitching. Have heard things are getting better with new hire and the bank is rlly prioritizing growth, but would be cautious. In general I’d guess that nyc will have better pe exits than clt. 

Don’t know much about the other banks

 

Thanks for the response. Do you know if Wells is prioritzing growth within their HC platform specifically and I know you said you don't know a lot about the other banks but is it more ideal for laterals/exits to have better brand name and less M&A experience or be in a boutique but be able to get M&A experience? 

 
Most Helpful

A molestiae sequi quo vel nisi. Itaque ab omnis qui non excepturi et quia. Ut sequi sit ipsam et sunt.

Iste nihil ipsa consequatur voluptatem. Aut accusantium explicabo maxime officiis eius voluptatem. Possimus culpa sint qui voluptatem voluptatibus soluta.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (78) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”